According to them, the DEK–AFF2 fusion gene was the likely driver event in head and neck squamous cell carcinoma, neoantigens derived from the DEK-AFF2 fusion may induce an immunostimulatory T cell response. Here, AFF2 is linked to head and neck squamous cell carcinoma.